On December 22, 2025, the U.S. Food and Drug Administration (FDA) approved an oral pill form of Wegovy — a glucagon-like peptide-1 (GLP-1) receptor agonist medication for weight loss. Until now, ...
It is thought about 1.6 million people are on weight-loss drugs in the UK. Some patients are able to get the injections ...
Wegovy is a prescription medicine used for weight loss, to reduce cardiovascular risks, and to treat metabolic dysfunction-associated steatohepatitis (MASH). It is available in two forms: a liquid for ...
Wegovy pill, the first FDA‑approved oral GLP‑1 for weight loss, is now available via WeightWatchers Med+ from $149 per month ...
Everyday Health on MSN
GLP-1 drugs for obesity: How to switch from the needle to a pill
Learn how to transition from injectable GLP-1s to oral options like Wegovy and Foundayo, with expert advice on dosing, side ...
If you’re weighing the option of Wegovy versus Zepbound for weight loss, here’s how the two medications compare in terms of ...
On January 5, 2026, Novo Nordisk announced it had launched an oral tablet version of its injectable GLP-1 weight-loss medication, Wegovy (semaglutide). The GLP-1 pill is still prescription-only, but ...
Chief Medical Officer at Central DuPage Hospital Dr. Tom Moran joins Bob Sirott to discuss a study that looks at the correlation between caffeine intake and the risk for diabetes, the new federal ...
Losing weight with the help of a prescription weight loss drug continues to increase in popularity. According to recent K FF polls, about one in eight U.S. adults takes a GLP-1 medication for weight ...
WeightWatchers Med+ is now offering an oral GLP-1 medication for weight loss. The new daily pill is the first FDA-approved oral GLP-1 for weight management. Clinical trials showed weight loss results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results